Clik here to view.
Prana Chief Scientific Advisor Receives Smithsonian American Ingenuity Award
MELBOURNE, Australia Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) is pleased to congratulate its Chief Scientist, Professor Rudy Tanzi, who has been awarded a Smithsonian American Ingenuity...
View ArticleClik here to view.
Pharco...
エジプト・アレクサンドリア （ビジネスワイヤ） — エジプトの一流医薬品メーカーのPharco Pharmaceuticals,Inc.は本日、遺伝子型4型の慢性C型肝炎ウイルス患者のravidasvirおよびソホスブビルによる併用療法の第3相臨床試験の進行段階の結果を発表しました。この試験はこの種の世界的試験としては最大規模となるものです。...
View ArticleClik here to view.
CSIRO Maintains Key Patent for shRNA Gene Silencing Technology After European...
CANBERRA, Australia Australia’s leading science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), has successfully defended another key patent for RNA interference...
View ArticleClik here to view.
Pharco Pharmaceuticals Inc.报告：Ravidasvir联合Sofosbuvir...
埃及亚历山大 (美国商业资讯) — 埃及领先的药品制造商Pharco Pharmaceuticals, Inc.今天发布了其ravidasvir联合sofosbuvir 治疗基因型4慢性丙型肝炎病毒感染患者的III期临床试验的深度结果，这是全球同类研究中样本量最大的试验。 该项延后发布的口头呈报题为：“Ravidasvir...
View ArticleClik here to view.
Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali®...
View ArticleClik here to view.
Nitto’s ND-L02-s0201:RNAi Anti-Fibrosis Drug for the Treatment of Liver...
OSAKA, Japan Japan’s leading diversified materials manufacturer Nitto Denko Corporation (TOKYO:6988)(ISIN:JP3684000007) reported preliminary results from their ongoing Phase1b/2 studies during The...
View ArticleClik here to view.
Cell Therapy Catapult Signs Memorandum of Understanding with Kanagawa...
LONDON The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today...
View ArticleClik here to view.
新加坡中央医院与Thermo Fisher Scientific合作探寻亚洲特异性癌症基因突变的发生率
加州卡尔斯巴德 (美国商业资讯) – 新加坡中央医院(SGH)与Thermo Fisher Scientific今天宣布缔结一项合作伙伴关系，将在Thermo Fisher的离子流下一代测序(NGS)平台上协同探寻与亚洲人群关联的癌症基因突变。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Singapore General Hospital and Thermo Fisher Scientific Collaborate to...
CARLSBAD, Calif. Singapore General Hospital (SGH) and Thermo Fisher Scientific today announced the establishment of a collaborative partnership that will work to identify cancer genetic mutations...
View ArticleClik here to view.
セル・セラピー・カタパルトが神奈川県と覚書を交わす
ロンドン 科学研究と商業化との間の橋渡しをすることで、英国の細胞・遺伝子療法産業の成長に専心する英国の組織セル・セラピー・カタパルトは本日、神奈川県と了解覚書を交わしたことを発表します。覚書に署名したのは神奈川県の黒岩祐治知事とセル・セラピー・カタパルトのキース・トンプソン最高経営責任者（CEO）です。...
View ArticleClik here to view.
bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to...
CAMBRIDGE, Mass. & SEOUL, Korea bluebird bio, Inc. (Nasdaq: BLUE) and ViroMed Co., Ltd. today announced that they have entered into an exclusive license agreement to research, develop and...
View ArticleClik here to view.
Samsung Bioepis’ RENFLEXIS® Infliximab Biosimilar Receives Regulatory...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved RENFLEXIS® – a biosimilar version of Remicade® (infliximab), also known as...
View ArticleClik here to view.
Promega NanoBiT Complementation Assay Named a Top 10 Innovation
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 MADISON, Wis. The Scientist named Promega NanoBiT™ (NanoLuc® Binary Technology) Assay as a Top 10 Innovation for 2015. This is the third...
View ArticleClik here to view.
Bellicum and Astellas Announce License Agreement for Cancer Target PSCA in...
HOUSTON & TOKYO Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM, “Bellicum”) and Astellas Pharma Inc. (TSE: 4503, “Astellas”) today announced that Agensys, Inc. (“Agensys”), an affiliate of...
View ArticleClik here to view.
Novogene and Illumina to Co-Develop NGS Diagnostic System for Reproductive...
BEIJING & SAN DIEGO Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly...
View ArticleClik here to view.
Sanofi Genzyme Announces Recipients of Patient Advocacy Leadership (PAL) Awards
CAMBRIDGE, Mass. Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the recipients of the fifth annual Patient Advocacy Leadership (PAL) awards. The global grant...
View ArticleClik here to view.
Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics...
OSAKA, Japan & MONTREAL Takeda Pharmaceutical Company Ltd. (TOKYO:4502) and enGene, Inc. today announced a strategic alliance to discover, develop and commercialize novel therapies for specialty...
View ArticleClik here to view.
武田薬品とenGene社の消化器系疾患に対する新規治療法開発に向けた戦略的提携について
大阪 & カナダ・モントリオール （ビジネスワイヤ） — 武田薬品工業株式会社（本社：大阪市中央区、以下「武田薬品」）とenGene, Inc.（本社：カナダ モントリオール、以下「enGene社」）は、このたび、enGene社の遺伝子導入基盤技術である“Gene...
View ArticleClik here to view.
POLARIS Deploys Clinical Genomic Tests on DNAnexus Platform
MOUNTAIN VIEW, Calif. DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that POLARIS (Personalized OMIC Lattice for Advanced Research and Improving...
View ArticleClik here to view.
武田与enGene建立胃肠病治疗新药开发战略联盟
日本大阪和蒙特利尔 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)与enGene, Inc.今天宣布一项战略联盟，采用enGene的“基因丸”(Gene Pill)基因投药平台发现、开发和商业化治疗胃肠(GI)专科疾病的新药。enGene采用其专利非病毒载体平台向肠壁细胞投放治疗基因，该战略联盟将发挥enGene在该领域的专项技能和知识产权地位的优势。 Smart News...
View Article